Currently holds positions in Humana Inc and Outlook Therapeutics Inc
Position | Company | Period |
---|---|---|
Independent Chairman of the Board | Humana Inc | Jan. 1, 2014 - |
Independent Director | Outlook Therapeutics Inc | Dec. 1, 2015 - |
Lead Independent Director | Humana Inc | Aug. 26, 2010 - Dec. 31, 2013 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-10-05 | 2022-10-05 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
15,662
+3.4%
1.2319,264 USD |
15,662 +3.4% | 1.23 | 19,264 USD | |
2022-10-05 | 2022-10-04 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
95,541
+26.4%
1.29123,248 USD |
95,541 +26.4% | 1.29 | 123,248 USD | |
2022-10-03 | 2022-10-03 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
41,798
+13.1%
1.2552,248 USD |
41,798 +13.1% | 1.25 | 52,248 USD | |
2022-10-03 | 2022-09-30 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
33,199
+11.6%
1.2641,831 USD |
33,199 +11.6% | 1.26 | 41,831 USD | |
2022-10-03 | 2022-09-29 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
13,800
+5.1%
1.1916,422 USD |
13,800 +5.1% | 1.19 | 16,422 USD | |
2022-02-28 | 2022-02-28 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
6,000
+2.5%
1.609,600 USD |
6,000 +2.5% | 1.60 | 9,600 USD | |
2022-02-28 | 2022-02-24 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
41,160
+20.8%
1.4660,094 USD |
41,160 +20.8% | 1.46 | 60,094 USD | |
2022-02-23 | 2022-02-23 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
79,535
+67.0%
1.44114,530 USD |
79,535 +67.0% | 1.44 | 114,530 USD | |
2022-02-23 | 2022-02-22 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
95,597
+413.5%
1.49142,440 USD |
95,597 +413.5% | 1.49 | 142,440 USD | |
2019-02-06 | 2019-02-04 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
5,983
+3.3%
0.804,786 USD |
5,983 +3.3% | 0.80 | 4,786 USD | |
2019-02-01 | 2019-02-01 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
8,200
+4.8%
0.776,314 USD |
8,200 +4.8% | 0.77 | 6,314 USD | |
2019-02-01 | 2019-01-31 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
6,300
+3.8%
0.754,725 USD |
6,300 +3.8% | 0.75 | 4,725 USD | |
2019-02-01 | 2019-01-30 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
4,890
+3.1%
0.723,521 USD |
4,890 +3.1% | 0.72 | 3,521 USD | |
2019-01-29 | 2019-01-29 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
5,400
+3.5%
0.733,942 USD |
5,400 +3.5% | 0.73 | 3,942 USD | |
2019-01-29 | 2019-01-28 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
15,884
+11.5%
0.7111,278 USD |
15,884 +11.5% | 0.71 | 11,278 USD | |
2019-01-29 | 2019-01-25 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
10,828
+8.5%
0.697,471 USD |
10,828 +8.5% | 0.69 | 7,471 USD | |
2019-01-24 | 2019-01-23 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
2,266
+1.8%
0.671,518 USD |
2,266 +1.8% | 0.67 | 1,518 USD | |
2019-01-24 | 2019-01-22 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
10,749
+9.4%
0.687,309 USD |
10,749 +9.4% | 0.68 | 7,309 USD | |
2019-01-18 | 2019-01-17 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
2,300
+2.1%
0.691,587 USD |
2,300 +2.1% | 0.69 | 1,587 USD | |
2019-01-18 | 2019-01-16 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
800
+0.7%
0.68544 USD |
800 +0.7% | 0.68 | 544 USD | |
2019-01-16 | 2019-01-15 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
2,266
+2.1%
0.701,586 USD |
2,266 +2.1% | 0.70 | 1,586 USD | |
2019-01-16 | 2019-01-14 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
4,399
+4.2%
0.713,123 USD |
4,399 +4.2% | 0.71 | 3,123 USD | |
2019-01-11 | 2019-01-10 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
6,053
+6.1%
0.704,237 USD |
6,053 +6.1% | 0.70 | 4,237 USD | |
2019-01-11 | 2019-01-09 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
2,792
+2.9%
0.732,038 USD |
2,792 +2.9% | 0.73 | 2,038 USD | |
2019-01-08 | 2019-01-08 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
6,410
+7.2%
0.654,167 USD |
6,410 +7.2% | 0.65 | 4,167 USD | |
2019-01-08 | 2019-01-07 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
5,166
+6.1%
0.633,255 USD |
5,166 +6.1% | 0.63 | 3,255 USD | |
2019-01-08 | 2019-01-04 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
6,205
+7.9%
0.593,661 USD |
6,205 +7.9% | 0.59 | 3,661 USD | |
2019-01-03 | 2019-01-03 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
4,200
+5.7%
0.592,478 USD |
4,200 +5.7% | 0.59 | 2,478 USD | |
2019-01-03 | 2019-01-02 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
1,640
+2.3%
0.59968 USD |
1,640 +2.3% | 0.59 | 968 USD | |
2019-01-03 | 2018-12-31 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
11,349
+18.6%
0.596,696 USD |
11,349 +18.6% | 0.59 | 6,696 USD | |
2018-12-26 | 2018-12-21 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
3,600
+9.5%
0.652,340 USD |
3,600 +9.5% | 0.65 | 2,340 USD |